1. Respiratory infection withchalmydia pneumoniae in middle-aged and older adult outpatients

   • D. H. Thom
   • J. T. Grayston
   • S. P. Wang

   Article Pages: 785 - 792

2. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement

   • F. Suter
   • A. Avai
   • F. Maggiolo

   Article Pages: 793 - 796

3. Prospective study ofCandida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients

   • P. Martino
   • C. Girmenia
   • A. Cassone

   Article Pages: 797 - 804

4. Three beta-lactamases isolated fromAeromonas salmonicida, including a carbapenemase not detectable by conventional methods

   • M. V. Hayes
   • C. J. Thomson
   • S. G. B. Amyes

   Article Pages: 805 - 811

5. Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection ofHelicobacter pylori infection

   • M. Trautmann
   • M. Moldrzyk
   • R. Marre

   Article Pages: 812 - 819

6. In vitro activity of biapenem against beta-lactamase producingEnterobacteriaceae

   • R. Alonso
   • A. Fdez-Aranguiz
   • R. Cisterna

   New Antimicrobial Agents Pages: 820 - 822

7. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin

   • A. Barry
   • P. Fuchs
   • L. Reller

   New Antimicrobial Agents Pages: 822 - 826

8. Evaluation of a commercial rRNA target amplification assay for detection ofMycobacterium tuberculosis complex in respiratory specimens

   • S. Ehlers
   • M. Pirmann
   • H. Hahn

   Note Pages: 827 - 829

9. Reduction in human listeriosis in barcelona, spain

   • J. Nolla-Salas
   • I. Gasser
   • A. Plasencia

   Letters Pages: 830 - 830

10. Luxuriant growth ofHelicobacter pylori andCampylobacter species in candle jars after primary isolation

    • Y. Holloway
    • J. Schiphuis
    • J. A. M. Snijder

    Letters Pages: 831 - 832

11. Problems with identification ofAcinetobacter species

    • R. E. Weaver

    Letters Pages: 832 - 832

12. Resistance to and hydrolysis of imipenem in nosocomial strains ofFlavobacterium meningosepticum

    • J. Blahová
    • M. Hupková
    • K. Kuboňová

    Letters Pages: 833 - 833

13. Introduction

    • J. O. Klein
    • R. Wise

    Current Topic: Introduction Pages: 837 - 838

14. Comparative microbiological activity and pharmacokinetics of cefprozil

    • R. Wise

    Current Topic: Review Pages: 839 - 845

15. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis

    • J. M. McCarty

    Current Topic: Article Pages: 846 - 850

16. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections

    • P. Ball

    Current Topic: Article Pages: 851 - 856

17. Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media

    • D. A. Kafetzis

    Current Topic: Article Pages: 857 - 865

18. Comparative studies of cefprozil in the management of skin and soft-tissue infections

    • T. Nolen

    Current Topic: Note Pages: 866 - 871

19. Announcements

    Announcement Pages: 872 - 872